Page 3839 – MPR

Redesigned Forteo Pen launched

Lilly has launched a redesigned pen-injector device for administering Forteo (teriparatide [recombinant] injection) that features a larger and wider body, a no-priming injection system, and color-coded parts for patient training and communication.

Kids-EEZE Chest Relief now available

Kids-EEZE Chest Relief now available

Quigley has launched over-the-counter Kids-EEZE Chest Relief, a chewable expectorant for the relief of cough and chest congestion in children ≥6 years of age.

Seroquel XR approved for bipolar depression and mania

AstraZeneca’s Seroquel XR (quetiapine fumarate extended-release tablets) has been approved for the treatment of depressive episodes in bipolar disorder, manic and mixed episodes in bipolar I disorder, and the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex.

RAPAFLO (Silodosin) 4mg, 8mg capsules by Watson

Rapaflo approved for BPH

The FDA has approved Rapaflo (silodosin, from Watson) for the treatment of benign prostatic hyperplasia (BPH).

Akten approved for eye surgery

The FDA has approved Akten (lidocaine ophthalmic gel 3.5%, from Akorn), a topical, preservative-free anesthetic for use in ocular procedures, including intravitreal injection and cataract, refractive and Lasik surgery.